The PsyIndex rose 9.2% final week after a turbulent week prior.

At least three privately-held psychedelic firms—Entheon Biomedical, Mindset Pharma and Cybin—introduced reverse merger transactions to change into publicly-traded.

 

Top Gainers

  • Revive Therapeutics Ltd.
    +59.39%
    (CSE: RVV) (OTC: RVVTF)
     
  • Empower Clinics Inc.
    +24.21%
    (CSE: CBDT) (OTC: EPWCF)
     
  • Numinus Wellness Inc.
    23.88%
    (TSX-V: NUMI)
Top Decliners

  • New Wave Holdings Inc.
    – 11.23%
    (CSE: SPOR) (OTC: TRMNF)
     
  • Yield Growth Corp.
    -3.48%
    (CSE: BOSS) (OTC: BOSQF)
     
  • Mydecine Innovations Inc.
    -2.98%
    (CSE: MYCO) (OTC: MYCOF

 

Corporate Developments

  • Cybin Corp. introduced a reverse-takeover transaction with Clarmin Explorations Inc. (TSX.V: CX) and a concurrent non-public placement of as much as $21 million. To date, Cybin has raised roughly $10,400,000 by an preliminary financing spherical and its collection A financing spherical.
     
  • Entheon Biomedical Corp. introduced a definitive settlement for a reverse-takeover with MPV Exploration Inc. (CSE: MPV) and a concurrent financing of no less than C$2 million.
     
  • Mindset Pharma Inc. introduced a reverse-takeover transaction with North Sur Resources (CSE: H) together with a non-public placement to lift as much as $1 million.
     
  • Field Trip Psychedelics Inc. launched a program referred to as Field Trip Basecamp that may deal with serving people affected by debilitating psychological well being points because of high-pressure occupations.
     
  • MindMed Inc. has formally launched Project Lucy, a business drug growth program for the therapy of hysteria issues.

 

Industry Developments

  • The Oregon Psilocybin Therapy Initiative introduced final week that it has obtained the required quantity of signatures for the measure to seem on the poll—marking one other step towards legalization in November. via The Hill

Source link